These 3 Patient Advocacy Groups Are Helping Solve Issues in the COVID-19 Pandemic
These three nonprofits are making a difference where it’s needed the most.
Bristol Myers Squibb
BMY
BMY
$57.75
$0.32
0.6%
Price as of July 13, 2020, 4:15 p.m. EDT
View Interactive BMY Charts
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
Interactive Chart
News & Analysis: Bristol Myers Squibb
The Fool has written over 1100 articles on Bristol Myers Squibb.
3 Stocks I'll Be Buying When the Market Crashes Again
These three companies have the resources and the positioning to survive the harshest of economic conditions.
3 Top Dividend Stocks to Buy Right Now
Sometimes, simple things like reliable income just make more sense.
Better Buy: Amgen vs. Bristol Myers Squibb
Here's how these two drugmakers stack up against each other.
3 Top Pharma Stocks to Buy in a Recession
These drugmakers' businesses shouldn't be significantly impacted by an economic downturn.
Why Is Everyone Talking About Bristol Myers Squibb Stock?
Here's why this cheap blue-chip pharma stock is a solid buy for dividend, value, and growth investors alike.
3 Top Value Stocks to Buy Right Now
They're not nearly as fun to talk about at cocktail parties, but these proven workhorses are still very affordable picks.
Better Buy: Biogen vs. Bristol Myers Squibb
Neither drugmaker has been a winner this year. But one appears to be a pretty safe bet to win in the future.
Could Bristol Myers Squibb Be a Millionaire-Maker Stock?
This healthcare stock could be a gamechanger for long-term investors who buy in today.
Have $500? Here Are the Best Stocks to Buy During a Correction
Growth? Value? Income? There are great deals available for all types of long-term investors.
